Cargando…
Therapy of cervical cancer using (131)I-labeled nanoparticles
OBJECTIVE: To evaluate the effectiveness of two kinds of Arg-Gly-Asp (RGD)-targeted (131)I-containing nanoliposomes for the treatment of cervical cancer in vitro and in vivo. METHODS: The nanoparticle liposomes designated RGD-(131)I-tyrosine peptide chain (TPC)-L and (131)I-RGD-L were prepared. The...
Autores principales: | Li, Wei, Sun, Danyang, Li, Ning, Shen, Yiming, Hu, Yiming, Tan, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023049/ https://www.ncbi.nlm.nih.gov/pubmed/29658363 http://dx.doi.org/10.1177/0300060518761787 |
Ejemplares similares
-
Radionuclide (131)I-labeled albumin-indocyanine green nanoparticles for synergistic combined radio-photothermal therapy of anaplastic thyroid cancer
por: Zhang, Xuemei, et al.
Publicado: (2022) -
Co-transfection with BMP2 and FGF2 via chitosan nanoparticles potentiates osteogenesis in human adipose-derived stromal cells in vitro
por: Hu, Ying, et al.
Publicado: (2021) -
Effect of (131)I Therapy on Complete Blood Count in Patients with Differentiated Thyroid Cancer
por: Rui, Zhongying, et al.
Publicado: (2021) -
Atractylenolide I alleviates ischemia/reperfusion injury by preserving mitochondrial function and inhibiting caspase-3 activity
por: Sun, Caiqin, et al.
Publicado: (2021) -
Radionuclide I-131 Labeled Albumin-Paclitaxel Nanoparticles for Synergistic Combined Chemo-radioisotope Therapy of Cancer
por: Tian, Longlong, et al.
Publicado: (2017)